Erleada is available as a 240mg tablet for patients with non-metastatic castration-resistant and metastatic castration-sensitive prostate cancer.

Related Keywords

Luca Dezzani , Janssen Scientific Affairs , Vice President , Medical Affairs , Solid Tumor ,